Photo via The Globe and Mail

Ontario court sides with patient appealing province’s refusal to cover out-of-country cancer treatment

Read the original at The Globe and Mail ↗
Cite

Kirkup, K. (2026, September 23). Ontario court sides with patient appealing province’s refusal to cover out-of-country cancer treatment. The Globe and Mail. https://www.theglobeandmail.com/canada/article-ontario-court-sides-with-patient-appealing-provinces-refusal-to-cover/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

The Globe and Mail · collected 2026-09-23 · by Kristy Kirkup

Quick Summary

An Ontario court ruled in favor of Alex Shved, a 37-year-old father with stage 4 melanoma, ordering the province to reconsider its refusal to cover his out-of-country cancer treatment by October 2. The judges found that denying funding for tumour-infiltrating lymphocyte (TIL) therapy was unreasonable and inadequately explained, given Shved’s dire prognosis without immediate access to the $515,000 US treatment. While Health Canada approved a commercial version of TIL therapy in August 2025, it is still under review for public funding in Canada.
Written by AI on 2026-09-23, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

In Ontario, The Ontario Superior Court of Justice ruled on Tuesday to quash the province’s refusal to cover out-of-country cancer treatment for Alex Shved, a 37-year-old father from Etobicoke with stage 4 melanoma. The court found that denying Mr. Shved's request for TIL therapy, which could extend his life, was unreasonable and inadequately explained by the province’s health program. Judges ordered an expedited review of the case, demanding a new decision by Oct. 2, or sooner if feasible. Justice Jean-Marc Labrosse noted that Mr. Shved is likely to die by Christmas without immediate treatment. His oncologist applied twice for OHIP coverage but was denied both times.

Written for “Ontario Cancer Treatment Rulings” on 2026-11-22, grounded in this article and the 2 other(s) covering the same event.

How they differ

2 outlets covered “Ontario Cancer Treatment Rulings”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

The Globe and MailThis outlet23 Sep

An Ontario court ruled in favor of Alex Shved, a 37-year-old father with stage 4 melanoma, ordering the province to reconsider its refusal to cover his out-of-country cancer treatment by October 2. The judges found that denying funding for tumour-infiltrating lymphocyte (TIL) therapy was unreasonable and inadequately explained, given Shved’s dire prognosis without immediate access to the $515,000 US treatment. While…

Ontario court sides with patient appealing province’s refusal to cover out-of-country cancer treatment (this article)
Toronto Star23 Sep

The Ontario Superior Court has overturned a previous decision by OHIP to deny coverage for out-of-country cancer treatment for Alex Shved, a 37-year-old man with Stage 4 melanoma. His oncologist had requested funding from the Ontario Health Insurance Plan (OHIP) for tumour-infiltrating lymphocyte therapy in the United States, but both an initial and reconsideration decision denied coverage before the court…

Court quashes OHIP denial of out-of-country treatment for man with terminal cancer →2 articles from Toronto Star on this story

Compared with similar articles

This article reads unscored and hedges 7% of its claims. Each row says how that neighbour differs.
Toronto Star
Hedges 0 of 2 claims Outlet record 65/100
Toronto Star
Leans left Hedges 1 of 24 claims Outlet record 65/100

Story

Ontario Cancer Treatment Rulings
Health · 3 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
29
sentences that state something as happening or true
Uncertain
7%
2 of 29 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
51/100
The Globe and Mail's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
3
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-23 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Globe and Mail · 1310 article(s) · 51 correction(s) detected
Running correction rate · 51 correction(s)

Who wrote this

Kristy Kirkup
19 article(s) here · 1 carrying a prediction
Menopause specialists are concerned about how Canadian patients will be affected by Pfizer’s recent decision to stop supplying a vaginal cream and oral estrogen tablets in Canada, while continuing to offer them in the U.S.
Previously, family physicians could apply a consult code for providing menopause care, but many felt the fee was not clearly defined, creating confusion about when it could be used.
“Use them and get going.” Mr. Gibson, 69, knows future research efforts won’t change the fact that ALS, which affects muscles involved in key functions such as breathing, will eventually take his life. But the grandfather, known by his family for his stubborn streak, is determined to push ahead while he can. After being diagnosed with ALS, Mr. Gibson said he had a choice to make: He could either feel bad about his situation or he could do whatever he could with his “last bit of time.” Tammy Moore, chief executive officer of ALS Canada, is urging the government to fund research that could be used to evaluate the demographics of patients across the country and ensure they have access to clinical trials.
Dr. Jerath said a possible explanation for the differences could be that female physicians may engage in more patient-centred communication and that they spend more time with their patients.
So depending on where the attack occurs, you could have a multitude of different symptoms, or you could have no symptoms at all.
By the end of a two-day interjurisdictional meeting, Canada’s provincial and territorial health ministers were able to receive assurances on funding extensions from Ottawa, but will need to convene again before 2027 to confirm the future of expiring transfer programs.
Canada’s provincial and territorial health ministers say Ottawa’s one-year extension of funding for mental health, addiction treatment and home care is not enough, and that federal plans would amount to a spending cut that is “the largest in a generation.”
The model could serve as an example for other centres across the country as Canada experiences rapid growth in its aging population.
An Ontario father of two with Stage 4 melanoma says he is heartbroken that the provincial government’s revised rules for out-of-country medical coverage will continue to bar access to a treatment that could save his and others’ lives.
At the time, a nurse told her any other surgeon would have done a hysterectomy because her situation was “a mess.”
Also by Kristy Kirkup
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 19 articles by Kristy Kirkup →

Topics

Etobicoke Florida OHIP Ontario The Ontario Superior Court of Justice

Subjects

Shved PERSON · 5× Jones PERSON · 2× OHIP ORG · 2× Ontario GPE · 2× Alex Shved PERSON · 1× Etobicoke GPE · 1× Florida GPE · 1× Jean‑Marc Labrosse PERSON · 1× Sharon Shore PERSON · 1× The Ontario Superior Court of Justice ORG · 1×

Narrative

On Tuesday, justices Jean‑Marc Labrosse and Sharon Shore set aside decisions that denied funding for Mr. Shved’s potentially life-saving treatment, finding the justifications unreasonable and inadequately explained. They also sent the matter back to the executive officer of the Ontario Public Drug Programs and requested a new decision with an expedited timeline, emphasizing that time is now “very tight.”
framing: assertive · carried by 1 article(s) · first seen 2026-09-23
“The record discloses that he will likely be dead by Christmas if he does not receive the requested treatment within a few weeks,” the justices said.

Claims (29 extracted, 2 hedged)

The Ontario Superior Court of Justice has quashed the province’s decision to refuse to cover out-of-country cancer treatment for a father of two with stage 4 melanoma, ordering a new decision by Oct. 2. asserted
Court → quash → Oct.
Alex Shved, a 37-year-old Etobicoke resident, had challenged the province’s decision and said Tuesday that the court’s judgment validates arguments he has put forward in his fight to see public drug coverage for tumour-infiltrating lymphocyte (TIL) therapy. asserted
he → challenge → therapy
His physicians support Mr. Shved accessing it in Florida. asserted
Shved → support → Florida
On Tuesday, justices Jean‑Marc Labrosse and Sharon Shore set aside decisions that denied funding for Mr. Shved’s potentially life-saving treatment, finding the justifications unreasonable and inadequately explained. They also sent the matter back to the executive officer of the Ontario Public Drug Programs and requested a new decision with an expedited timeline, emphasizing that time is now “very tight.” asserted
time → set → timeline
“The record discloses that he will likely be dead by Christmas if he does not receive the requested treatment within a few weeks,” the justices said. asserted
justices → disclose → weeks
A third judge, Justice David Corbett, agreed that the decisions should be quashed. asserted
decisions → agree → ?
However, he disagreed on the approach supported by justices Labrosse and Shore. asserted
he → disagree → Labrosse
He said he would have directed the executive officer to recommend treatment and would have instructed OHIP’s general manager to expedite a funding decision. asserted
he → say → decision
In August, 2025, Health Canada approved a commercial version of TIL therapy called lifileucel. asserted
Canada → approve → therapy
But it is not available in Canada outside of clinical trials because it is still being reviewed for public funding. asserted
it → review → funding
Mr. Shved is one of three Ontario melanoma patients who spoke with The Globe and Mail about their fears and frustrations waiting to access TIL therapy while it makes its way through the country’s complex system for funding new medical treatments. asserted
it → speak → treatments
He applied for a provincial out-of-country program to see if it would pay for him to be treated in the U.S. asserted
him → apply → U.S.
But he was denied and told the program isn’t intended to be used as an interim funding route for drugs that could eventually qualify for public coverage. uncertain
that → deny → coverage
A single treatment of lifileucel costs US$515,000, not including the cost of a stay at an American hospital. asserted
treatment → cost → hospital
So he filed for a judicial review in court in June. asserted
he → file → June
He said the process to review medications for funding can take years and that there is no way for a Canadian patient to access the therapy. asserted
patient → say → therapy
“What is somebody that’s got stage 4 cancer to do?” he said. asserted
he → get → cancer
“They don’t have two years to wait for this to get approved. asserted
this → have → years
And I think that is exactly what the judges saw.” asserted
judges → think → what
Mr. Shved, who has a five-month-old baby and a two-year-old, has also appealed to legislators to help. asserted
who → have → legislators
Days after having surgery on his left arm to remove a tumour, he continued to reach out to politicians. asserted
he → have → politicians
He e- asserted
He → e → ?
“The Court has made clear that OHIP cannot deny potentially life-saving treatment based on blanket internal policies, unsupported claims about harm to ‘the system’ or superficial reasoning,” he wrote. uncertain
he → make → system
A spokesperson for Ms. Jones did not immediately offer comment Tuesday on the court’s decision. asserted
spokesperson → offer → decision
Mr. Shved said he has spoken directly with Ms. Jones in the past couple of months but lamented that “she has done nothing.” asserted
she → say → nothing
He said that makes the legal challenge his only available avenue. asserted
challenge → say → ?
And while he said he grows discouraged from time to time when he does not receive anything in return from politicians, he remains hopeful. asserted
he → say → politicians
He wants to help other patients “wrongly denied this treatment for absurd and unlawful reasons.” asserted
He → want → reasons
“That’s, I think, what keeps me going and inspires me to continue.” With reports from Kelly Grant in Toronto asserted
what → ’ → Toronto
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support